Broadcast Date: 
  • Time: 

In the past decade, the synthetic biology market has seen fledgling companies rise to IPO smashing power players, as the demand for high-quality, engineered biomolecules grows exponentially. The synthesis of DNA molecules and libraries has always been at the vanguard of synthetic biology endeavors but has seen its share of challenges that scientists have to navigate. Technological advancements and democratization of synthesis modalities have expanded access to an even wider range of life science investigators—presenting new challenges, but also a host of opportunities for new solutions.

In this GEN webinar, Dr. Marc Brehme will introduce us to Ribbon Biolabs’ innovative platform for the automated synthesis of long DNA molecules and will showcase the relevance of precise, loss-less DNA quantification for synthetic biology. Additionally, Dr. Beatrice Marg-Haufe will tell us more about some exciting new technology for Tecan’s line of liquid handling workstations that allows quantifying of nucleic acids without sample loss using UV-based concentration and purity measurements in a hanging drop.

A live Q&A session followed the presentation, offering a chance to pose questions to our expert panelists.

Marc Brehme, PhD
Marc Brehme, PhD
CTO
Ribbon Biolabs
Beatrice Marg-Haufe, PhD
Beatrice Marg-Haufe, PhD
Senior Market Manager
Tecan

Tecan logo